Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-864 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-626 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-809 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-867 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-865 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1278 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-01 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
filingDate |
2002-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbb9df7510c6592ec21d1c4e1c38fd41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b565b5f854204df4257d9f5f7a67c903 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f57f403c76adec1ac59911f2eb365896 |
publicationDate |
2008-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2008262204-A1 |
titleOfInvention |
Recombinant antibodies for the detection and neutralization of anthrax toxin |
abstract |
A composition and method for treating a host having or at risk of infection by Bacillus anthracis using an affinity matured antibody or portion thereof derived from a monoclonal antibody. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8420607-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010233174-A9 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014194600-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102470156-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019144527-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009246200-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9310366-B2 |
priorityDate |
2001-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |